These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11812402)

  • 1. Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease.
    Domingo P; Muñiz-Diaz E; Baraldès MA; Arilla M; Barquet N; Pericas R; Juárez C; Madoz P; Vázquez G
    Am J Med; 2002 Jan; 112(1):19-25. PubMed ID: 11812402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal disease and polymorphism of FcgammaRIIa (CD32) in late complement component-deficient individuals.
    Platonov AE; Kuijper EJ; Vershinina IV; Shipulin GA; Westerdaal N; Fijen CA; van de Winkel JG
    Clin Exp Immunol; 1998 Jan; 111(1):97-101. PubMed ID: 9472667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of human Fc gamma RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease.
    Platonov AE; Shipulin GA; Vershinina IV; Dankert J; van de Winkel JG; Kuijper EJ
    Clin Infect Dis; 1998 Oct; 27(4):746-50. PubMed ID: 9798027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patients.
    Yun HR; Koh HK; Kim SS; Chung WT; Kim DW; Hong KP; Song GG; Chang HK; Choe JY; Bae SC; Salmon JE; Yoo DH; Kim TY; Kim SY
    Lupus; 2001; 10(7):466-72. PubMed ID: 11480843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals.
    Fijen CA; Bredius RG; Kuijper EJ; Out TA; De Haas M; De Wit AP; Daha MR; De Winkel JG
    Clin Exp Immunol; 2000 May; 120(2):338-45. PubMed ID: 10792385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of genetically determined host factors to the prognosis of meningococcal disease.
    Domingo P; Muñiz-Diaz E; Baraldès MA; Arilla M; Barquet N; Pericas R; Juárez C; Madoz P; Vázquez G
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):634-7. PubMed ID: 15243816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils.
    Sanders LA; Feldman RG; Voorhorst-Ogink MM; de Haas M; Rijkers GT; Capel PJ; Zegers BJ; van de Winkel JG
    Infect Immun; 1995 Jan; 63(1):73-81. PubMed ID: 7806386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children.
    Bredius RG; Derkx BH; Fijen CA; de Wit TP; de Haas M; Weening RS; van de Winkel JG; Out TA
    J Infect Dis; 1994 Oct; 170(4):848-53. PubMed ID: 7930726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia.
    Yee AM; Phan HM; Zuniga R; Salmon JE; Musher DM
    Clin Infect Dis; 2000 Jan; 30(1):25-8. PubMed ID: 10619728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fcgamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms.
    Manger K; Repp R; Spriewald BM; Rascu A; Geiger A; Wassmuth R; Westerdaal NA; Wentz B; Manger B; Kalden JR; van de Winkel JG
    Arthritis Rheum; 1998 Jul; 41(7):1181-9. PubMed ID: 9663473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FcgammaRIIA polymorphisms in Streptococcus pneumoniae infection.
    Yuan FF; Wong M; Pererva N; Keating J; Davis AR; Bryant JA; Sullivan JS
    Immunol Cell Biol; 2003 Jun; 81(3):192-5. PubMed ID: 12752683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Fcgamma receptor IIa (cd32) gene polymorphism and anti-malarial IgG subclass antibodies to asexual blood-stage antigen of Plasmodium falciparum in an unstable malaria endemic area of Iran.
    Zakeri S; Mashhadi R; Mehrizi AA; Djadid ND
    Exp Parasitol; 2013 May; 134(1):115-21. PubMed ID: 23458236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fcgamma receptor polymorphisms determine the magnitude of in vitro phagocytosis of Streptococcus pneumoniae mediated by pneumococcal conjugate sera.
    Jansen WT; Breukels MA; Snippe H; Sanders LA; Verheul AF; Rijkers GT
    J Infect Dis; 1999 Sep; 180(3):888-91. PubMed ID: 10438387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Fcgamma receptor IIa genotype with chronic periodontitis in Caucasians.
    Yamamoto K; Kobayashi T; Grossi S; Ho AW; Genco RJ; Yoshie H; De Nardin E
    J Periodontol; 2004 Apr; 75(4):517-22. PubMed ID: 15152814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FcgammaRIIa and FcgammaRIIIb polymorphisms were not associated with meningococcal disease in Western Norway.
    Smith I; Vedeler C; Halstensen A
    Epidemiol Infect; 2003 Apr; 130(2):193-9. PubMed ID: 12729187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fcgamma receptor IIA H/R131 polymorphism in patients with antiphospholipid antibodies.
    Atsumi T; Caliz R; Amengual O; Khamashta MA; Hughes GR
    Thromb Haemost; 1998 May; 79(5):924-7. PubMed ID: 9609222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Fc receptor IIA polymorphism and infection in children with sickle cell disease.
    Norris CF; Surrey S; Bunin GR; Schwartz E; Buchanan GR; McKenzie SE
    J Pediatr; 1996 Jun; 128(6):813-9. PubMed ID: 8648541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fcgamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms.
    Manger K; Repp R; Jansen M; Geisselbrecht M; Wassmuth R; Westerdaal NA; Pfahlberg A; Manger B; Kalden JR; van de Winkel JG
    Ann Rheum Dis; 2002 Sep; 61(9):786-92. PubMed ID: 12176802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients.
    Duits AJ; Bootsma H; Derksen RH; Spronk PE; Kater L; Kallenberg CG; Capel PJ; Westerdaal NA; Spierenburg GT; Gmelig-Meyling FH
    Arthritis Rheum; 1995 Dec; 38(12):1832-6. PubMed ID: 8849356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between neutrophil FcgammaRIIa allelic polymorphism and anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis.
    Tse WY; Abadeh S; McTiernan A; Jefferis R; Savage CO; Adu D
    Clin Exp Immunol; 1999 Jul; 117(1):198-205. PubMed ID: 10403936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.